Nanobody: A Small Antibody with Big Implications for Tumor Therapeutic Strategy

The development of monoclonal antibody treatments for successful tumor-targeted therapies took several decades. However, the efficacy of antibody-based therapy is still confined and desperately needs further improvement. Nanobodies are the recombinant variable domains of heavy-chain-only antibodies,...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Shuyang, Ding, Ziqiang, Yang, Xiaomei, Zhao, Xinyue, Zhao, Minlong, Gao, Li, Chen, Qu, Xie, Shenxia, Liu, Aiqun, Yin, Shihua, Xu, Zhiping, Lu, Xiaoling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997558/
https://www.ncbi.nlm.nih.gov/pubmed/33790553
http://dx.doi.org/10.2147/IJN.S297631

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997558/
https://www.ncbi.nlm.nih.gov/pubmed/33790553
http://dx.doi.org/10.2147/IJN.S297631

Ejemplares similares